Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 May 20;5(6):741-751.
doi: 10.1002/acn3.571. eCollection 2018 Jun.

Aging related cognitive changes associated with Alzheimer's disease in Down syndrome

Nicholas C Firth  1 , Carla M Startin  2   3   4 , Rosalyn Hithersay  2   3   4 , Sarah Hamburg  2   3   4 , Peter A Wijeratne  1 , Kin Y Mok  4   5   6 , John Hardy  4   5   7 , Daniel C Alexander  1 ; LonDownS Consortium; André Strydom  2   3   4   8
Affiliations

Aging related cognitive changes associated with Alzheimer's disease in Down syndrome

Nicholas C Firth et al. Ann Clin Transl Neurol. .

Abstract

Objective: Individuals with Down syndrome (DS) have an extremely high genetic risk for Alzheimer's disease (AD), however, the course of cognitive decline associated with progression to dementia is ill-defined. Data-driven methods can estimate long-term trends from cross-sectional data while adjusting for variability in baseline ability, which complicates dementia assessment in those with DS.

Methods: We applied an event-based model to cognitive test data and informant-rated questionnaire data from 283 adults with DS (the largest study of cognitive functioning in DS to date) to estimate the sequence of cognitive decline and individuals' disease stage.

Results: Decline in tests of memory, sustained attention/motor coordination, and verbal fluency occurred early, demonstrating that AD in DS follows a similar pattern of change to other forms of AD. Later decline was found for informant measures. Using the resulting staging model, we showed that adults with a clinical diagnosis of dementia and those with APOE 3:4 or 4:4 genotype were significantly more likely to be staged later, suggesting that the model is valid.

Interpretation: Our results identify tests of memory and sustained attention may be particularly useful measures to track decline in the preclinical/prodromal stages of AD in DS whereas informant-measures may be useful in later stages (i.e. during conversion into dementia, or postdiagnosis). These results have implications for the selection of outcome measures of treatment trials to delay or prevent cognitive decline due to AD in DS. As clinical diagnoses are generally made late into AD progression, early assessment is essential.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Positional variance diagrams show the maximum likelihood event sequence. Each entry represents the proportion of samples with each biomarker in each position ranging from 0 in white to 1 in black. (A) Positional variance diagram of the Markov chain Monte Carlo samples generated during fitting of the event‐based model (B) diagram of the samples generated during bootstrapping of the model.
Figure 2
Figure 2
Histogram of event‐based model stages for all participants, colored by age group.
Figure 3
Figure 3
Histogram of event‐based model stages for old adult participants, colored by clinical diagnosis.
Figure 4
Figure 4
Histogram of event‐based model stages colored by APOE genotype. (A) Young adults (B) Old adults.
See this image and copyright information in PMC

References

    1. Bittles AH, Bower C, Hussain R, Glasson EJ. The four ages of Down syndrome. Eur J Public Health 2007;17:221–225. - PubMed
    1. Wiseman FK, Al‐Janabi T, Hardy J, et al. A genetic cause of Alzheimer disease: mechanistic insights from Down syndrome. Nat Rev Neurosci 2015;16:564–574. - PMC - PubMed
    1. George‐Hyslop PS, Tanzi RE, Polinsky RJ, et al. The genetic defect causing familial Alzheimer's disease maps on chromosome 21. Science 1987;235:885–890. - PubMed
    1. Patterson D, Gardiner K, Kao FT, et al. Mapping of the gene encoding the beta‐amyloid precursor protein and its relationship to the Down syndrome region of chromosome 21. Proc Natl Acad Sci 1988;85:8266–8270. - PMC - PubMed
    1. Mann DMA, Esiri MM. The pattern of acquisition of plaques and tangles in the brains of patients under 50 years of age with Down's syndrome. J Neurol Sci 1989;89:169–179. - PubMed